TY - JOUR
T1 - Generation of induced pluripotent stem (iPS) cells derived from a murine model of Pompe disease and differentiation of Pompe-iPS cells into skeletal muscle cells
AU - Kawagoe, Shiho
AU - Higuchi, Takashi
AU - Meng, Xing Li
AU - Shimada, Yohta
AU - Shimizu, Hiromi
AU - Hirayama, Reimi
AU - Fukuda, Takahiro
AU - Chang, Hsi
AU - Nakahata, Tatsutoshi
AU - Fukada, So Ichiro
AU - Ida, Hiroyuki
AU - Kobayashi, Hiroshi
AU - Ohashi, Toya
AU - Eto, Yoshikastu
N1 - Funding Information:
We thank Dr. Toshio Kitamura (University of Tokyo) for providing the Plat-E packaging cell line [28] and Drs. Sasaki and E. Kikuchi (Jikei University) for helping with the electron microscopy. This work is supported by grants of a Ministry of Welfare (Lysosomal research study and Regenerative medicine).
PY - 2011/9
Y1 - 2011/9
N2 - Our study is the first to demonstrate the ability to generate iPS cells from a mouse model of Pompe disease. Initially, mouse tail tip fibroblasts were harvested from male, 8-week-old (GAA) knockout mice, and three reprogramming factors (Oct3/4, Sox2 and Klf4) were transfected into the isolated donor cells using a retroviral vector. These iPS cells also showed decreased levels of GAA enzymatic activity and strong positive staining with periodic acid-Schiff (indicating the accumulation of glycogen) and acid phosphatase (lysosomal activation marker). Pompe-iPS cells were differentiated into skeletal muscle cells in Matrigel®-coated plates. Spindle-shaped skeletal muscle cells were successfully generated from Pompe-iPS cells and showed spontaneous contraction and positive staining with the myosin heavy chain antibody. Electron microscopic analysis of the skeletal muscle cells showed typical morphological features, including Z-bands, I-bands, A-bands and H-bands, which were visible in wild-type and Pompe cells. Furthermore, Pompe skeletal muscle cells accumulated massive glycogen in lysosomes. This study indicates that the iPS and skeletal muscle cells generated in this study could also be a useful disease model for studies investigating the pathogenesis and treatment of skeletal muscle in Pompe disease.
AB - Our study is the first to demonstrate the ability to generate iPS cells from a mouse model of Pompe disease. Initially, mouse tail tip fibroblasts were harvested from male, 8-week-old (GAA) knockout mice, and three reprogramming factors (Oct3/4, Sox2 and Klf4) were transfected into the isolated donor cells using a retroviral vector. These iPS cells also showed decreased levels of GAA enzymatic activity and strong positive staining with periodic acid-Schiff (indicating the accumulation of glycogen) and acid phosphatase (lysosomal activation marker). Pompe-iPS cells were differentiated into skeletal muscle cells in Matrigel®-coated plates. Spindle-shaped skeletal muscle cells were successfully generated from Pompe-iPS cells and showed spontaneous contraction and positive staining with the myosin heavy chain antibody. Electron microscopic analysis of the skeletal muscle cells showed typical morphological features, including Z-bands, I-bands, A-bands and H-bands, which were visible in wild-type and Pompe cells. Furthermore, Pompe skeletal muscle cells accumulated massive glycogen in lysosomes. This study indicates that the iPS and skeletal muscle cells generated in this study could also be a useful disease model for studies investigating the pathogenesis and treatment of skeletal muscle in Pompe disease.
KW - Acid α-glucosidase
KW - Induced pluripotent stem (iPS)
KW - Pompe disease
KW - Reprogramming factor
KW - Skeletal muscle
UR - http://www.scopus.com/inward/record.url?scp=80052531213&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80052531213&partnerID=8YFLogxK
U2 - 10.1016/j.ymgme.2011.05.020
DO - 10.1016/j.ymgme.2011.05.020
M3 - Article
C2 - 21703893
AN - SCOPUS:80052531213
SN - 1096-7192
VL - 104
SP - 123
EP - 128
JO - Molecular Genetics and Metabolism
JF - Molecular Genetics and Metabolism
IS - 1-2
ER -